Home / Resource Library / Brentuximab vedotin and association with event free survival (EFS) in children with newly diagnosed high risk Hodgkin lymphoma (HL)
Brentuximab vedotin and association with event free survival (EFS) in children with newly diagnosed high risk Hodgkin lymphoma (HL)